Vorasidenib; a new hope for managing gliomas after surgery?

Neurosurg Rev. 2024 Oct 4;47(1):732. doi: 10.1007/s10143-024-03011-w.
No abstract available

Publication types

  • Editorial
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms* / drug therapy
  • Brain Neoplasms* / surgery
  • Glioma* / drug therapy
  • Glioma* / surgery
  • Humans
  • Pyridines / therapeutic use
  • Triazines / therapeutic use

Substances

  • Pyridines
  • Antineoplastic Agents
  • Triazines